galactose has been researched along with nitroarginine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abignente, E; Barbarisi, A; Boatto, G; Curcio, A; Grimaldi, A; Lettieri, M; Luongo, E; Marino, G; Melisi, D; Nieddu, M; Rimoli, MG; Romano, MF; Romano, S; Rosso, F; Tortora, C | 1 |
Curcio, A; De Chiaro, M; de Novellis, V; Giordano, C; Luongo, L; Maione, S; Marabese, I; Melisi, D; Palazzo, E; Rimoli, MG; Rossi, F; Siniscalco, D; Soukupova, M | 1 |
2 other study(ies) available for galactose and nitroarginine
Article | Year |
---|---|
Galactosyl derivative of N(omega)-nitro-L-arginine: study of antiproliferative activity on human thyroid follicular carcinoma cells.
Topics: Adenocarcinoma, Follicular; Apoptosis; Biological Assay; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Flow Cytometry; Galactose; Humans; Nitric Oxide; Nitroarginine; Thyroid Neoplasms; Time Factors | 2009 |
The galactosylation of N(ω)-nitro-L-arginine enhances its anti-nocifensive or anti-allodynic effects by targeting glia in healthy and neuropathic mice.
Topics: Analgesics; Animals; Astrocytes; Blood Pressure; Caspases; Galactose; Gene Expression Regulation, Enzymologic; Glucose Transporter Type 3; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Microglia; Neuralgia; Neuroglia; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Nitroarginine; Prodrugs; Psychomotor Performance; RNA, Messenger; Sciatic Nerve; Time Factors | 2011 |